Press releases

Release
08.03.2019

VALBIOTIS Provides 2018 Financial Results and Corporate Update

Download
Release
11.02.2019

VALBIOTIS obtains the European patent for VALEDIA®

Download
Release
04.02.2019

VALBIOTIS strengthens its Board of Directors with the appointment of Murielle CAZAUBIEL

Download
Release
30.01.2019

Update on the liquidity contract (in French)

Download
Release
24.01.2019

VALBIOTIS appoints Josep INFESTA, international expert in Consumer Healthcare, Head of Global Business Development

Download
Release
07.01.2019

VALBIOTIS is taking part in the 37th J.P. Morgan Healthcare conference, from 7 to 10 January 2019 in San Francisco, California

Download
Release
28.11.2018

VALBIOTIS recognized for its IPO at the 2018 INVESTOR AWARDS

Download
Release
12.11.2018

VALBIOTIS announces expansion of application for VALEDIA to include NASH prevention

Download
Release
06.11.2018

VALBIOTIS confirms the publication of the results from international Phase IIA clinical study evaluating VALEDIA® for the risk reduction of type 2 diabetes, by mid-2019

Download